Skip to search boxSkip to navigationSkip to main content

Semaglutide Reduces CV Events in High-Risk Patients with Type 2 Diabetes Mellitus

  • Mark H. Ebell
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Journal (Volume, Issue Number)

American family physician (Volume 95, Issue 6)

Publication milestones

  • Published - 03/15/2017

Publication status

Published - 03/15/2017

ISSN

0002-838X

Publication IDs

  • Scopus: 85056257283
  • PubMed: 28318215

Publication metrics

Metrics

SciVal
Author count
1
SciVal
Paper percentile
25
Scopus
citations
Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1

PlumX

Captures
46
Citation count
1